| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.31 | 1e-05 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.0001 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0006 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |